---
title: Dr. Jeffrey Scott on Pharma’s Role in Understanding the Value of Novel, Expensive Therapies
description: Jeffrey A. Scott, MD, chief medical officer, Integra Connect, discusses how pharma can help community oncologists understand the value of novel and expensive therapies.
---

# Newsroom

For Press Contact

[media@integraconnect.com](mailto:media@integraconnect.com)

Announcements

[In The News](https://insights.integraconnect.com/news?type=in-the-news) [Thought Leadership](https://insights.integraconnect.com/news?type=thought-leadership)

[

Back

](https://insights.integraconnect.com/news?type=in-the-news)

### Dr. Jeffrey Scott on Pharma’s Role in Understanding the Value of Novel, Expensive Therapies

Apr 17, 2019

Life Sciences

Specialty Practices

Click here to [read the original article at AJMC.](https://www.ajmc.com/view/dr-jeffrey-scott-on-pharmas-role-in-understanding-the-value-of-novel-expensive-therapies)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Integra Connect",
    "url" : "https://insights.integraconnect.com/news/author/integra-connect"
  },
  "dateModified" : "2023-05-24T01:48:29.277Z",
  "datePublished" : "2019-04-17T13:00:00.000Z",
  "headline" : "Dr. Jeffrey Scott on Pharma’s Role in Understanding the Value of Novel, Expensive Therapies",
  "mainEntityOfPage" : {
    "@id" : "https://insights.integraconnect.com/news/dr-jeffrey-scott-on-pharmas-role-in-understanding-the-value-of-novel-expensive-therapies",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://insights.integraconnect.com/hubfs/IntegraConnect%20/ic-logo-text-dark-gray.png"
    },
    "name" : "Integra Connect"
  }
}
```